LOXL2 and breast carcinoma: LOXL2 also increases the expression and secretion of prolymphangiogenic factors in fibroblasts in breast cancer in a HIF-1α-dependent manner, stimulating the Akt-Snail and Erk signalling pathways to enhance lymphangiogenesis and lymph node metastasis in breast tumours 59.